Skip to main content

Latest SEC Filings — Page 150

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Zentalis Prices $80.5M Public Offering at $3.50/Share
Form 8-KZNTL · Form 8-K · 2026-08-14
Hydrofarm Q2 Loss Narrows to $10.6M; Sells Aurora Peat for $16M to Cut Debt
ProForm 8-KHYFM · Form 8-K · 2026-08-14
Aterian 10-Q: Going Concern Doubt and New Nasdaq Delisting Risk After Asset Sale
ProForm 10-QATER · Form 10-Q · 2026-08-14
Vycor Medical Q2 2026: Going Concern Warning, Material Weakness, Revenue Down 16%
ProForm 10-QVYCO · Form 10-Q · 2026-08-14
Zentalis Prices 23M Share Offering at $3.50, Raising $75.1M
Form 424B5ZNTL · Form 424B5 · 2026-08-14
Quantumsphere Flags Ineffective Controls and Going Concern Doubt as Merger Deadline Passes
ProForm 10-QQUMS · Form 10-Q · 2026-08-14
Vireo Growth Q2 Revenue Soars 335% to $209M, Nears Breakeven
ProForm 10-QVREOF · Form 10-Q · 2026-08-14
Gabelli Group Cuts MSG Sports Stake Below 5% After Heavy Selling
Form SCHEDULE 13D/AMSGS · Form SCHEDULE 13D/A · 2026-08-14
Atlas Lithium Moves to Development Stage with Updated Neves Project Reserves
Form 10-K/AATLX · Form 10-K/A · 2026-08-14
LFTD Partners Reports $5.6M Loss, Going Concern Warning, and $6.6M Inventory Write-Down
ProForm 10-QLIFD · Form 10-Q · 2026-08-14
Adial's 10-Q Flags Material Weakness, Nasdaq Deficiency, and a $52M Quarterly Loss
ProForm 10-QADIL · Form 10-Q · 2026-08-14
Jasper Posts Q2 Loss, Extends Cash Runway to 2H 2028
Form 8-KJSPR · Form 8-K · 2026-08-14
Atlassian FY26 10-K: Revenue Up 26% to $6.57B, Restructuring Charges $285M, $1.8B Buyback Executed
Form 10-KTEAM · Form 10-K · 2026-08-14
SPAC's Cash Dwindles to $23K as NuCube Merger Deadline Looms
Form 10-QLPBB · Form 10-Q · 2026-08-14
Rocket One Q2 Loss Widens to $3.8M; Cash at $7.9M
Form 10-QRKTO · Form 10-Q · 2026-08-14
Replimune 10-Q: Going Concern Lifted After $141M Raise and FDA Approval
ProForm 10-QREPL · Form 10-Q · 2026-08-14
374Water's Q2 10-Q Flags Going Concern, $1.02M Debt Extinguishment Loss, and Material Weakness
ProForm 10-QSCWO · Form 10-Q · 2026-08-14
Cemtrex Q3: Going Concern Doubt, Nasdaq MVLS Risk, and New Acquisition
ProForm 10-QCETX · Form 10-Q · 2026-08-14
Beeline Holdings Flags Going Concern, Needs $6M as Cash Drops to $1.4M
ProForm 10-QBLNE · Form 10-Q · 2026-08-14
SPAC Reiterates Going Concern Warning as Cash Dwindles to $707K
ProForm 10-QMBVI · Form 10-Q · 2026-08-14
VIDA Global Posts Q2 Loss as Material Weakness Lingers
ProForm 10-QVIDA · Form 10-Q · 2026-08-14
Vivos Therapeutics Reports Q2 Loss, Going Concern Warning, and High-Cost Financing
ProForm 10-QVVOS · Form 10-Q · 2026-08-14
20/20 Biolabs Q2 Revenue Jumps 36% but Losses Widen; Cash at $4.5M
ProForm 10-QAIDX · Form 10-Q · 2026-08-14
Blackstone's Q2 13F Reveals $1.37B SpaceX Stake and $2.31B S&P 500 Put Position
Form 13F-HRBX · Form 13F-HR · 2026-08-14
Processa 10-Q Details Vidya Merger Terms, Elion Settlement, and $200M PIPE Ownership Split
ProForm 10-QPCSA · Form 10-Q · 2026-08-14
Evofem Biosciences Reports $16.5M Loss, Warns of Going Concern Doubt
ProForm 10-QEVFM · Form 10-Q · 2026-08-14
Jet.AI Flags Going Concern, Posts Q2 Loss, and Continues ATM Dilution
ProForm 10-QJTAI · Form 10-Q · 2026-08-14
Callan JMB Q2 10-Q: Going Concern, Nasdaq Delisting Notices, and Material Weakness
ProForm 10-QCJMB · Form 10-Q · 2026-08-14
Bioxytran Q2 10-Q: Going Concern, $2.69M Loss, CEO Grant
ProForm 10-QBIXT · Form 10-Q · 2026-08-14
Nomadar 10-Q: Going Concern Warning, Material Weaknesses, and New Financing
ProForm 10-QNOMA · Form 10-Q · 2026-08-14